Duff & Phelps Investment Management Co. Sells 76,450 Shares of Sabra Healthcare REIT, Inc. $SBRA

Duff & Phelps Investment Management Co. trimmed its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 3.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,472,988 shares of the real estate investment trust’s stock after selling 76,450 shares during the quarter. Duff & Phelps Investment Management Co.’s holdings in Sabra Healthcare REIT were worth $46,096,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of SBRA. Engineers Gate Manager LP boosted its holdings in Sabra Healthcare REIT by 3,190.3% during the 2nd quarter. Engineers Gate Manager LP now owns 3,179,303 shares of the real estate investment trust’s stock valued at $58,626,000 after acquiring an additional 3,082,677 shares during the period. Norges Bank purchased a new stake in Sabra Healthcare REIT in the second quarter worth $54,385,000. Balyasny Asset Management L.P. bought a new stake in shares of Sabra Healthcare REIT during the second quarter worth $49,955,000. Qube Research & Technologies Ltd lifted its position in shares of Sabra Healthcare REIT by 856.5% during the second quarter. Qube Research & Technologies Ltd now owns 1,398,965 shares of the real estate investment trust’s stock worth $25,797,000 after purchasing an additional 1,252,708 shares during the last quarter. Finally, Schroder Investment Management Group boosted its stake in shares of Sabra Healthcare REIT by 511.3% during the second quarter. Schroder Investment Management Group now owns 1,447,248 shares of the real estate investment trust’s stock valued at $26,687,000 after purchasing an additional 1,210,485 shares during the period. 99.40% of the stock is owned by institutional investors.

Analyst Ratings Changes

SBRA has been the topic of several recent analyst reports. Truist Financial raised their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a research note on Tuesday, January 20th. Citizens Jmp boosted their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Scotiabank upped their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Monday, March 2nd. Wells Fargo & Company raised their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Finally, Wall Street Zen downgraded shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research note on Friday, January 23rd. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $21.80.

Sabra Healthcare REIT Price Performance

SBRA opened at $20.65 on Thursday. The company has a market capitalization of $5.21 billion, a price-to-earnings ratio of 32.27, a PEG ratio of 1.67 and a beta of 0.64. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. Sabra Healthcare REIT, Inc. has a 12-month low of $15.75 and a 12-month high of $21.07. The business’s fifty day simple moving average is $19.58 and its 200-day simple moving average is $18.99.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The firm had revenue of $201.35 million during the quarter, compared to the consensus estimate of $201.97 million. During the same quarter in the previous year, the firm earned $0.36 earnings per share. The business’s revenue was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. The ex-dividend date of this dividend was Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio is presently 187.50%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.